(Q46982495)

27 December 2017

title

Effect of loss of heterozygosity of the c-kit gene on prognosis after hepatectomy for metastatic liver gastrointestinal stromal tumors (English)

1 reference

27 December 2017

1 reference

1 reference

Hirotoshi Kikuchi

1

1 reference

27 December 2017

Masayoshi Yamamoto

2

1 reference

27 December 2017

Yoshihiro Hiramatsu

3

1 reference

27 December 2017

Megumi Baba

4

1 reference

27 December 2017

Manabu Ohta

5

1 reference

27 December 2017

Kinji Kamiya

6

1 reference

27 December 2017

Tatsuo Tanaka

7

1 reference

27 December 2017

Shohachi Suzuki

8

1 reference

27 December 2017

Haruhiko Sugimura

9

1 reference

27 December 2017

Masatoshi Kitagawa

10

1 reference

27 December 2017

Toshikazu Kanai

11

1 reference

27 December 2017

Yasuhiko Kitayama

12

1 reference

27 December 2017

Tatsuo Kanda

13

1 reference

27 December 2017

Ken Nishikura

14

1 reference

27 December 2017

Hiroyuki Konno

15

1 reference

27 December 2017

publication date

1 November 2007

1 reference

27 December 2017

published in

Cancer Science

1 reference

27 December 2017

volume

98

1 reference

27 December 2017

issue

11

1 reference

27 December 2017

page(s)

1734-1739

1 reference

27 December 2017

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

PDGFRA activating mutations in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Gastrointestinal stromal tumors: a spectrum of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Immunohistochemical and genetic features of gastric and metastatic liver gastrointestinal stromal tumors: sequential analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Helpful parameter for malignant potential of gastrointestinal stromal tumors (GIST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Chromosomal numerical abnormality profiles of gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

Results of Hepatic Resection for Sarcoma Metastatic to Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00592.X

10.1111/J.1349-7006.2007.00592.X

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017